ABSTRACT
Background Diagnostic testing is essential for disease surveillance and test-trace-isolate efforts. Here, we aimed to investigate if residential area sociodemographic characteristics and test accessibility were associated with COVID-19 testing rates.
Methods We included information on 421 542 patient-initiated COVID-19 PCR tests from Uppsala County in Sweden from 24 June, 2020 to 9 February, 2022. Using Poisson regression analyses, we investigated whether the Care Need Index (CNI; median 1.0, IQR 0.8, 1.4), a composite measure of sociodemographic factors used in Sweden to allocate primary healthcare resources, was associated with aggregated COVID-19 daily testing rates after adjustments for community transmission. We further assessed if distance to the nearest testing station influenced testing. Lastly, we performed a difference-in-difference analysis of the opening of a testing station targeting a disadvantaged neighbourhood.
Results We observed that CNI, i.e. primary healthcare need, was negatively associated with COVID-19 testing rates in inhabitants aged 5-69 years. More pronounced differences were noted across younger age groups and in Uppsala City, with test rate ratios in children (5-14 years) ranging from 0.56 (95% CI 0.47-0.66) to 0.88 (95% CI 0.81-0.95) across the three pandemic waves. Longer distance to testing station was linked to lower testing rates, foremost in less densely populated areas. Furthermore, the opening of the targeted testing station was associated with increased testing, including twice as high testing rates in individuals aged 70-105, supporting an intervention effect.
Conclusions Ensuring accessible testing across all residential areas constitutes a promising tool to decrease differences and inequalities in testing.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research project received financial support from the Primary Health and Care internal competitive funding at Region Uppsala and from Vinnova (2020-03173), both by grants awarded to MM as principal investigator.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Swedish Ethical Review Authority (DNR 2020-04210 and DNR 2021-01915).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
1. Refined the aim of the study to determine whether residential area sociodemographic characteristics were associated with COVID-19 testing rates. 2. Included analysis to understand the role of distance to testing station. 3. Used difference-in-difference analysis to assess whether the opening of a testing station targeting a disadvantaged neighbourhood with high community transmission increased testing.
Data Availability
Restrictions apply to the availability of the testing and vaccination data, which were used under license and ethical approval. The data are however available from the authors upon reasonable request and with written permission from the Ethical Review Authority in Sweden. Information on postal code areas included in analyses and the code used in the project are available on Github (https://doi.org/10.5281/zenodo.7919372).
